Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1987 Dec;25(12):2391–2394. doi: 10.1128/jcm.25.12.2391-2394.1987

Evaluation of latex-based heterophile antibody assay for diagnosis of acute infectious mononucleosis.

L Cook 1, J Midgett 1, D Willis 1, B Clinton 1, J D Folds 1
PMCID: PMC269496  PMID: 2828417

Abstract

The diagnosis of an acute episode of infectious mononucleosis (IM) is made on the basis of clinical symptoms and serological evidence for development of heterophile antibodies. In an effort to obtain a very sensitive and specific assay for diagnosis of IM, we have developed MERISTAR:IM. The MERISTAR assay uses latex beads coated with purified bovine heterophile antigen. We compared the sensitivity and specificity and performance characteristics of the latex-based test to those of the commercially available erythrocyte-based Monospot test with serum samples from 363 suspected-IM patients and controls. A total of 28 samples from patients with confirmed IM were positive with the MERISTAR assay, while only 23 of the samples were positive with the Monospot assay. The two assays had equal specificity, as each test gave two false-positive results. In the technical performance of the assay, the MERISTAR assay was simpler and faster to perform than the Monospot assay.

Full text

PDF
2391

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Basson V., Sharp A. A. Monospot: a differential slide test for infectious mononucleosis. J Clin Pathol. 1969 May;22(3):324–325. doi: 10.1136/jcp.22.3.324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Evans A. S., Niederman J. C., Cenabre L. C., West B., Richards V. A. A prospective evaluation of heterophile and Epstein-Barr virus-specific IgM antibody tests in clinical and subclinical infectious mononucleosis: Specificity and sensitivity of the tests and persistence of antibody. J Infect Dis. 1975 Nov;132(5):546–554. doi: 10.1093/infdis/132.5.546. [DOI] [PubMed] [Google Scholar]
  3. Henle W., Henle G. E., Horwitz C. A. Epstein-Barr virus specific diagnostic tests in infectious mononucleosis. Hum Pathol. 1974 Sep;5(5):551–565. doi: 10.1016/s0046-8177(74)80006-7. [DOI] [PubMed] [Google Scholar]
  4. Høiby E. A., Tjade T., Røtterud O. J. Evaluation of ten commercial heterophile antibody tests for infectious mononucleosis. Acta Pathol Microbiol Immunol Scand C. 1985 Aug;93(4):145–151. doi: 10.1111/j.1699-0463.1985.tb02937.x. [DOI] [PubMed] [Google Scholar]
  5. Klemola E., Von Essen R., Henle G., Henle W. Infectious-mononucleosis-like disease with negative heterophil agglutination test. Clinical features in relation to Epstein-Barr virus and cytomegalovirus antibodies. J Infect Dis. 1970 Jun;121(6):608–614. doi: 10.1093/infdis/121.6.608. [DOI] [PubMed] [Google Scholar]
  6. Papaevangelou G., Roumeliotou A., Alexiou D., Politou E., Papadatos C. Diagnostic value of IgG and IgM antibodies to capsid antigen of Epstein-Barr virus in infectious mononucleosis. J Infect Dis. 1977 Sep;136(3):428–431. doi: 10.1093/infdis/136.3.428. [DOI] [PubMed] [Google Scholar]
  7. Reedman B. M., Klein G. Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer. 1973 May;11(3):499–520. doi: 10.1002/ijc.2910110302. [DOI] [PubMed] [Google Scholar]
  8. Shibley G. P., Manousos M., Munch K., Zelljadt I., Fisher L., Mayyasi S., Harewood K., Stevens R., Jensen K. E. New method for large-scale growth; and concentration of the Epstein-Barr viruses. Appl Environ Microbiol. 1980 Dec;40(6):1044–1048. doi: 10.1128/aem.40.6.1044-1048.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Taylor R. N., Ehrhard H. B., Marcus S. Evaluation of tests for infectious mononucleosis through proficiency testing. Health Lab Sci. 1976 Jan;13(1):34–44. [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES